Avata Biosciences Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
Avata Biosciences General Information
Description
Operator of a biopharmaceutical company intended to improve the lives of patients living with neurological disease. The company specializes in developing technology that produces cannabinoid APIs, creates hydrophilic conical structures with space to internalize cannabinoid molecules, and utilizes synthetically derived cannabinoids to focus on neuroscience drug discovery with assets in clinical development and benefits from the experience gained in cannabinoid drug development, enabling patients with neuroscience prescription medicines to have assistance with serious diseases.
Contact Information
Website
www.avatabio.comCorporate Office
- 6 Stratton Street
- Mayfair
- London W1J 8LD
- England, United Kingdom
Corporate Office
- 6 Stratton Street
- Mayfair
- London W1J 8LD
- England, United Kingdom
Avata Biosciences Timeline
Avata Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 3. Early Stage VC | Completed | Clinical Trials - Phase 1 | ||||
| 2. Seed Round | 07-Mar-2024 | $5.67M | $5.9M | Completed | Clinical Trials - Phase 1 | |
| 1. Angel (individual) | 14-Nov-2022 | $229K | $229K | Completed | Clinical Trials - Phase 1 |
Avata Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 31,667 | $0.001264 | $7.98 | $7.98 | 1x | $7.98 | 19.25% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Avata Biosciences Comparisons
Industry
Financing
Details
Avata Biosciences Competitors (4)
One of Avata Biosciences’s 4 competitors is Xenon Pharmaceuticals, a Formerly VC-backed company based in Burnaby, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals | Formerly VC-backed | Burnaby, Canada | ||||
| Biohaven | Formerly VC-backed | New Haven, CT | ||||
| SK Biopharmaceuticals | Corporation | Seongnam, South Korea | ||||
| Jazz Pharmaceuticals | Formerly VC-backed | Dublin, Ireland |
Avata Biosciences Signals
Avata Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Harwood Private Capital | Mezzanine | Minority | ||
| 5 Horizons Capital | Venture Capital | Minority |
Avata Biosciences FAQs
-
When was Avata Biosciences founded?
Avata Biosciences was founded in 2022.
-
Where is Avata Biosciences headquartered?
Avata Biosciences is headquartered in London, United Kingdom.
-
What is the size of Avata Biosciences?
Avata Biosciences has 12 total employees.
-
What industry is Avata Biosciences in?
Avata Biosciences’s primary industry is Drug Discovery.
-
Is Avata Biosciences a private or public company?
Avata Biosciences is a Private company.
-
What is Avata Biosciences’s current revenue?
The current revenue for Avata Biosciences is .
-
How much funding has Avata Biosciences raised over time?
Avata Biosciences has raised $45.9M.
-
Who are Avata Biosciences’s investors?
Harwood Private Capital and 5 Horizons Capital have invested in Avata Biosciences.
-
Who are Avata Biosciences’s competitors?
Xenon Pharmaceuticals, Biohaven, SK Biopharmaceuticals, and Jazz Pharmaceuticals are competitors of Avata Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process